BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16830336)

  • 21. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.
    Fernàndez V; Hartmann E; Ott G; Campo E; Rosenwald A
    J Clin Oncol; 2005 Sep; 23(26):6364-9. PubMed ID: 16155021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microsatellite instability analysis in typical and progressed mantle cell lymphoma and B-cell chronic lymphocytic leukemia.
    Sanz-Vaqué L; Colomer D; Bosch F; López-Guillermo A; Dreyling MH; Bosch F; Montserrat E; Campo E
    Haematologica; 2001 Feb; 86(2):181-6. PubMed ID: 11224488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas.
    Jardin F; Ruminy P; Kerckaert JP; Parmentier F; Picquenot JM; Quief S; Villenet C; Buchonnet G; Tosi M; Frebourg T; Bastard C; Tilly H
    Haematologica; 2008 Apr; 93(4):543-50. PubMed ID: 18287131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive correlation between allelic loss at chromosome 14q24-31 and poor prognosis of patients with renal cell carcinoma.
    Kaku H; Ito S; Ebara S; Ouchida M; Nasu Y; Tsushima T; Kumon H; Shimizu K
    Urology; 2004 Jul; 64(1):176-81. PubMed ID: 15245966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative gene expression deregulation in mantle-cell lymphoma: correlation with clinical and biologic factors.
    Kienle D; Katzenberger T; Ott G; Saupe D; Benner A; Kohlhammer H; Barth TF; Höller S; Kalla J; Rosenwald A; Müller-Hermelink HK; Möller P; Lichter P; Döhner H; Stilgenbauer S
    J Clin Oncol; 2007 Jul; 25(19):2770-7. PubMed ID: 17563396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas.
    Ripperger T; von Neuhoff N; Kamphues K; Emura M; Lehmann U; Tauscher M; Schraders M; Groenen P; Skawran B; Rudolph C; Callet-Bauchu E; van Krieken JH; Schlegelberger B; Steinemann D
    Haematologica; 2007 Apr; 92(4):460-8. PubMed ID: 17488656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis.
    Katzenberger T; Kienle D; Stilgenbauer S; Höller S; Schilling C; Mäder U; Puppe B; Petzoldt C; Sander S; Bullinger L; Stöcklein H; Kalla J; Hartmann E; Adam P; Ott MM; Müller-Hermelink HK; Rosenwald A; Ott G
    Br J Haematol; 2008 Aug; 142(4):538-50. PubMed ID: 18564361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of gene copy number aberrations in mantle cell lymphoma by a single quantitative multiplex PCR assay: clinicopathological relevance and prognosis value.
    Jardin F; Picquenot JM; Parmentier F; Ruminy P; Cornic M; Penther D; Bertrand P; Lanic H; Cassuto O; Humbrecht C; Lemasle E; Wautier A; Bastard C; Tilly H
    Br J Haematol; 2009 Sep; 146(6):607-18. PubMed ID: 19594747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma.
    Stöcklein H; Smardova J; Macak J; Katzenberger T; Höller S; Wessendorf S; Hutter G; Dreyling M; Haralambieva E; Mäder U; Müller-Hermelink HK; Rosenwald A; Ott G; Kalla J
    Oncogene; 2008 Apr; 27(18):2613-25. PubMed ID: 17982487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene-dosage regulated candidate genes.
    Schraders M; Jares P; Bea S; Schoenmakers EF; van Krieken JH; Campo E; Groenen PJ
    Br J Haematol; 2008 Oct; 143(2):210-21. PubMed ID: 18699851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma.
    Lee WC; Balsara B; Liu Z; Jhanwar SC; Testa JR
    Cancer Res; 1996 Oct; 56(19):4297-301. PubMed ID: 8813110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variant t(2;11)(p11.2;q13) without IGK involvement in a case of mantle cell lymphoma.
    Woroniecka R; Grygalewicz B; Pienkowska-Grela B; Rymkiewicz G; Konecki R; Swoboda P; Janik P
    Cancer Genet Cytogenet; 2007 Jun; 175(2):154-8. PubMed ID: 17556072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alteration of chromosome arm 6p is characteristic of primary mediastinal B-cell lymphoma, as identified by genome-wide allelotyping.
    Rigaud G; Moore PS; Taruscio D; Scardoni M; Montresor M; Menestrina F; Scarpa A
    Genes Chromosomes Cancer; 2001 Jun; 31(2):191-5. PubMed ID: 11319807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on the molecular biology of mantle cell lymphoma.
    Bertoni F; Rinaldi A; Zucca E; Cavalli F
    Hematol Oncol; 2006 Mar; 24(1):22-7. PubMed ID: 16402392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inversions of chromosomes 2 and 6 in mantle cell lymphoma. Cytogenetic, FISH, and molecular studies.
    Pedrazzini E; Cerretini R; Noriega MF; Narbaitz M; Palacios MF; Negri P; Bengió R; Slavutsky I
    Cancer Genet Cytogenet; 2006 Jun; 167(2):164-7. PubMed ID: 16737918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cytogenetics of mantle cell lymphoma].
    Obukhova TN; Lorie IuIu; Vodinskaia LA; Alimova GA; Nikitin EA; Samoĭlova RS; Kaplanskaia IB; Domracheva EV
    Ter Arkh; 2004; 76(7):70-7. PubMed ID: 15379132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of chromosomal markers in the diagnosis of mantle cell lymphoma (MCL).
    Woroniecka R; Pieńkowska-Grela B; Grygalewicz B; Rygier J; Witkowska A; Rymkiewicz G; Jarosińska-Romejko J
    J Appl Genet; 2002; 43(4):545-53. PubMed ID: 12441639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas.
    Navarro A; Beà S; Fernández V; Prieto M; Salaverria I; Jares P; Hartmann E; Mozos A; López-Guillermo A; Villamor N; Colomer D; Puig X; Ott G; Solé F; Serrano S; Rosenwald A; Campo E; Hernández L
    Cancer Res; 2009 Sep; 69(17):7071-8. PubMed ID: 19690137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent polymorphic changes but not mutations of TRAIL receptors DR4 and DR5 in mantle cell lymphoma and other B-cell lymphoid neoplasms.
    Fernàndez V; Jares P; Beà S; Salaverria I; Guino E; de Sanjosé S; Colomer D; Ott G; Montserrat E; Campo E
    Haematologica; 2004 Nov; 89(11):1322-31. PubMed ID: 15531454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
    Kresse SH; Ohnstad HO; Paulsen EB; Bjerkehagen B; Szuhai K; Serra M; Schaefer KL; Myklebost O; Meza-Zepeda LA
    Genes Chromosomes Cancer; 2009 Aug; 48(8):679-93. PubMed ID: 19441093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.